Literature DB >> 7926337

Disordered gastric motor function in diabetes mellitus.

M Horowitz1, R Fraser.   

Abstract

The application of novel investigative techniques has demonstrated that disordered gastric motility occurs frequently in diabetes mellitus. Gastric emptying is abnormal in about 50% of diabetic patients and delay in gastric emptying of nutrient-containing meals is more common than rapid emptying. The blood glucose concentration influences gastric motility in diabetes. In IDDM patients, gastric emptying is retarded during hyperglycaemia and may be accelerated by hypoglycaemia. Gastroparesis therefore does not necessarily reflect irreversible autonomic neuropathy and blood glucose concentrations must be monitored when gastric motility is evaluated in diabetic patients. There is a poor relationship between gastric emptying and gastrointestinal symptoms and the mechanisms by which abnormal motility causes symptoms are unclear. The introduction of new gastrokinetic drugs has improved therapeutic options for the management of symptomatic patients with gastroparesis considerably. The contribution of disordered gastric emptying to poor glycaemic control is unclear, but the demonstration that the rate of gastric emptying is a major factor in normal blood glucose homeostasis suggests that this is likely to be significant.

Entities:  

Mesh:

Year:  1994        PMID: 7926337     DOI: 10.1007/bf00403371

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  57 in total

1.  Hyperglycaemia stimulates pyloric motility in normal subjects.

Authors:  R Fraser; M Horowitz; J Dent
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

2.  The effect of laboratory stressors on glycemic control and gastrointestinal transit time.

Authors:  E H Blair; R R Wing; A Wald
Journal:  Psychosom Med       Date:  1991 Mar-Apr       Impact factor: 4.312

3.  Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis.

Authors:  J Tack; J Janssens; G Vantrappen; T Peeters; V Annese; I Depoortere; E Muls; R Bouillon
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

4.  Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.

Authors:  R J Fraser; M Horowitz; A F Maddox; J Dent
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

5.  Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus.

Authors:  E Schvarcz; M Palmér; J Aman; B Lindkvist; K W Beckman
Journal:  Diabet Med       Date:  1993 Aug-Sep       Impact factor: 4.359

6.  Dual effects of cisapride on gastric emptying and antropyloroduodenal motility.

Authors:  R Fraser; M Horowitz; A Maddox; J Dent
Journal:  Am J Physiol       Date:  1993-02

7.  Prognostic implication of gastroparesis in patients with diabetes mellitus.

Authors:  T K Chaudhuri; S Fink
Journal:  Clin Auton Res       Date:  1992-08       Impact factor: 4.435

8.  Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus.

Authors:  M Wegener; G Börsch; J Schaffstein; C Luerweg; F Leverkus
Journal:  Dig Dis       Date:  1990       Impact factor: 2.404

9.  Reduced postprandial blood glucose levels in recently diagnosed non-insulin-dependent diabetics secondary to pharmacologically induced delayed gastric emptying.

Authors:  W T Phillips; J G Schwartz; C A McMahan
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

Review 10.  Disorders of gastrointestinal motility associated with diabetes mellitus.

Authors:  M Feldman; L R Schiller
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

View more
  36 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

Review 2.  Autonomic dysfunction and the gastrointestinal tract.

Authors:  M Bittinger; J Barnert; M Wienbeck
Journal:  Clin Auton Res       Date:  1999-04       Impact factor: 4.435

3.  Metoclopramide in the treatment of diabetic gastroparesis.

Authors:  Allen Lee; Braden Kuo
Journal:  Expert Rev Endocrinol Metab       Date:  2010

4.  Relation between cholecystokinin and antral innervation in the control of gastric emptying in the rat.

Authors:  A Higham; C Vaillant; B Yegen; D G Thompson; G J Dockray
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

5.  Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance.

Authors:  Georgios C Boronikolos; Björn A Menge; Nina Schenker; Thomas G K Breuer; Jan-Michel Otte; Sascha Heckermann; Freimut Schliess; Juris J Meier
Journal:  Diabetologia       Date:  2015-03-01       Impact factor: 10.122

6.  Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

7.  The effect of acute hyperglycaemia on small intestinal motility in normal subjects.

Authors:  A Russo; R Fraser; M Horowitz
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

8.  The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects.

Authors:  M Horowitz; K M Cunningham; J M Wishart; K L Jones; N W Read
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

9.  [13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function.

Authors:  D Ziegler; P Schadewaldt; A Pour Mirza; R Piolot; B Schommartz; M Reinhardt; H Vosberg; H Brösicke; F A Gries
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 10.  Liraglutide in the management of type 2 diabetes.

Authors:  Estela Wajcberg; Amatur Amarah
Journal:  Drug Des Devel Ther       Date:  2010-10-22       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.